Dinesh V. Patel, the Chief Executive Officer of Protagonist Therapeutics, has executed a sale of shares amounting to $7.5 million following the exercise of stock options. This transaction reflects Patel's decision to convert his options into equity, subsequently selling the shares on the open market. The details regarding the specific number of shares sold and the timing of the transaction have not been disclosed. Protagonist Therapeutics is a biopharmaceutical company focused on developing novel therapies for various diseases.
Related Articles
Don't miss out on breaking stories and in-depth articles.